Augmentation de l'immunogénicité de la nucléoprotéine de l'influenza par multimérisation in vitro

Authors: Russell, Alexis
Advisor: Savard, PierreLeclerc, Denis
Abstract: The emergence of the highly pathogenic H5N1 avian influenza and the pandemic of 2009 have pushed scientists to find novel vaccinations strategies such as directing the immune response towards the internal proteins of the influenza. In this study, we have used recombinant nucleoprotein (rNP) as a vaccine basis since it is well conserved among the influenza A strains and it can confer cross-protection. To enhance the low immunogenicity of the rNP, we multimerized it using synthetic RNA as a scaffold to form Nucleocapsid-like-particles (NLP). The multimerization increased the cellular and humoral immunogenicity of NP and addition of the PAL adjuvant increased it even further. The NLP-PAL candidate vaccine was not able to fully protect mice from a lethal challenge after one immunization. A prime-boost immunization increased the humoral and cellular response but further experiments are needed to see if the prime-boost strategy can protect against a lethal influenza challenge.
Document Type: Mémoire de maîtrise
Issue Date: 2015
Open Access Date: 24 April 2018
Grantor: Université Laval
Collection:Thèses et mémoires

Files in this item:
Description SizeFormat 
31652.pdfTexte3.12 MBAdobe PDFThumbnail
All documents in CorpusUL are protected by Copyright Act of Canada.